Table 3

PSA bounce in each group
Hormone naive Neo-adjuvant ADT
monotherapy Combined EBRT monotherapy Combined EBRT
(n=103) (n=38) (n=34) (n=17)
PSA elevation rate of 0.1 ng/mL or greater 51 (50%) 25 (66%) 9 (27%) 6 (35%)
Frequency of PSA bounce 29 (28%) 12 (32%) 3 (18%) 15 (18%)
Time to bounce (mos) 17.4, 17, (5-36) 14.8, 11.5 (5-35) 13.7, 8.5, (5-26) 18.3, 15, (14-26)
Mean, median, (range)
Height (ng/mL) 0.51, 0.34, (0.13-1.74) 0.48, 0.26, (0.12-1.85) 0.19, 0.16, (0.10-0.40) 0.90, 0.68, (0.16-1.87)
Mean, median, (range)
Duration (mos) 9.1, 6.0, (3-36) 11.8, 11.5, (2-31) 6.0, 6.0, (3-9) 15.3, 17.0, (7-22)
Mean, median, (range)
3-yr bounce free rate (%) 68.8 80.6 66.7 80.9

Tanaka et al.

Tanaka et al. BMC Urology 2012 12:28   doi:10.1186/1471-2490-12-28

Open Data